EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma
about
High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomasPhase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers.The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.Sulfated Galactans from Red Seaweed Gracilaria fisheri Target EGFR and Inhibit Cholangiocarcinoma Cell Proliferation.Expression and activation of EGFR and STAT3 during the multistage carcinogenesis of intrahepatic cholangiocarcinoma induced by 3'-methyl-4 dimethylaminoazobenzene in rats.Expression and significance of annexin A2 in patients with gastric adenocarcinoma and the association with E-cadherin.Essential role of polymorphism of Gab1, EGFR, and EGF for the susceptibility of biliary tract cancer.ACGH detects distinct genomic alterations of primary intrahepatic cholangiocarcinomas and matched lymph node metastases and identifies a poor prognosis subclass.
P2860
Q34998503-12F1C66A-8F2F-492E-9058-9F74CFE4318FQ36677934-503D37F2-F01E-4D68-B617-EE435E8BC699Q38238094-7F54C4BB-720B-49C5-99E1-178A689D7F73Q38849599-B9D39527-92F1-46A4-A565-0E280748263FQ41105428-537F2319-02D2-4364-8C69-D993328EA198Q42096061-D62DC1B5-F2B1-49A3-9B15-C8BC85E4708CQ44025843-D5287F60-FA5A-4FAF-A7FE-92793F82120FQ55656403-0DB6B053-94ED-4F85-B3A7-FE903746641F
P2860
EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
EGFR, FLT1 and heparanase as m ...... survival in cholangiocarcinoma
@ast
EGFR, FLT1 and heparanase as m ...... survival in cholangiocarcinoma
@en
EGFR, FLT1 and heparanase as m ...... survival in cholangiocarcinoma
@nl
type
label
EGFR, FLT1 and heparanase as m ...... survival in cholangiocarcinoma
@ast
EGFR, FLT1 and heparanase as m ...... survival in cholangiocarcinoma
@en
EGFR, FLT1 and heparanase as m ...... survival in cholangiocarcinoma
@nl
prefLabel
EGFR, FLT1 and heparanase as m ...... survival in cholangiocarcinoma
@ast
EGFR, FLT1 and heparanase as m ...... survival in cholangiocarcinoma
@en
EGFR, FLT1 and heparanase as m ...... survival in cholangiocarcinoma
@nl
P2093
P2860
P1433
P1476
EGFR, FLT1 and heparanase as m ...... survival in cholangiocarcinoma
@en
P2093
Andreas-Claudius Hoffmann
Daniela E Aust
Eray Goekkurt
Jan Stoehlmacher-Williams
Peter V Danenberg
Sylvia Lehmann
P2860
P304
P356
10.1371/JOURNAL.PONE.0064186
P407
P577
2013-05-21T00:00:00Z